Royalty Pharma plc Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2024: 17.37%

Royalty Pharma plc Return on Equity (ROE) is 17.37% for the Trailing 12 Months (TTM) ending September 30, 2024, a 3,336.79% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Royalty Pharma plc Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.51%.
  • Royalty Pharma plc Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2021 was 11.90%, a -66.26% change year over year.
  • Royalty Pharma plc Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2020 was 35.28%.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share